ArticleFuture oncology (London, England)2022

CSF1 receptor inhibition of tenosynovial giant cell tumor using novel disease-specific MRI measures of tumor burden.

Charles Peterfy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.